{"id":48353,"date":"2022-09-14T12:01:56","date_gmt":"2022-09-14T10:01:56","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/global-hemophilia-market-report-2022-rising-adoption-of-prophylaxis-treatment-to-drive-sector-growth-researchandmarkets-com\/"},"modified":"2022-09-14T12:01:56","modified_gmt":"2022-09-14T10:01:56","slug":"global-hemophilia-market-report-2022-rising-adoption-of-prophylaxis-treatment-to-drive-sector-growth-researchandmarkets-com","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/global-hemophilia-market-report-2022-rising-adoption-of-prophylaxis-treatment-to-drive-sector-growth-researchandmarkets-com\/","title":{"rendered":"Global Hemophilia Market Report 2022: Rising Adoption of Prophylaxis Treatment to Drive Sector Growth &#8211; ResearchAndMarkets.com"},"content":{"rendered":"<div>\n<p>DUBLIN&#8211;(BUSINESS WIRE)&#8211;The <a target=\"_blank\" href=\"https:\/\/www.researchandmarkets.com\/reports\/5607083\/hemophilia-market-analysis-by-type-type-a-b?utm_source=BW&amp;utm_medium=PressRelease&amp;utm_code=sx9jt6&amp;utm_campaign=1749424+-+Global+Hemophilia+Market+Report+2022%3A+Rising+Adoption+of+Prophylaxis+Treatment+to+Drive+Sector+Growth&amp;utm_exec=como322prd\" rel=\"nofollow noopener\" shape=\"rect\">&#8220;Hemophilia Market Analysis by Type (Type A, B, C,), by Treatment (Prophylaxis, On-Demand), by Therapy (Gene, Replacement, Immune Tolerance Induction (ITI) Therapy), and by Region &#8211; Forecast to 2029&#8221;<\/a> report has been added to <strong>ResearchAndMarkets.com&#8217;s<\/strong> offering.\n<\/p>\n<p><a href=\"https:\/\/mms.businesswire.com\/media\/20220914005481\/en\/1571401\/4\/logo.jpg\"><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20220914005481\/en\/1571401\/21\/logo.jpg\"><\/a><\/p>\n<p>\nThe global hemophilia market size is estimated to be USD 12.6 billion in 2021 and is expected to witness a CAGR of 5.79% during the forecast period. Rising adoption of prophylaxis treatment is a key driver for the growth of the global hemophilia market.\n<\/p>\n<p>\nAdditionally, increasing cases of hemophilia in new-borns, growing investment in R&amp;D activities for new product development, and rise in favourable initiatives taken by the government are some of the other drivers propelling the market growth. Nevertheless, lack of knowledge regarding hemophilia among developing economies and low acceptance rates of advanced products are expected to restrain the global market growth.\n<\/p>\n<p>\n<strong>Regional Insights<\/strong>\n<\/p>\n<p>\nIn 2021, North America accounted for the largest revenue share in the global market and is expected to maintain its dominance during the forecast period. This is attributed to the growing consciousness about the benefits of early detection of hemophilia, favourable reimbursement policies by the government, and increasing preference for prophylaxis treatment in this region.\n<\/p>\n<p>\nAsia Pacific market is projected to exhibit the fastest CAGR over the forecast period owing to the growing number of hemophilic patients, introduction of new drugs in the market, and increasing awareness regarding technologically advanced products in this region.\n<\/p>\n<p>\n<strong>Market Segmentation<\/strong>\n<\/p>\n<p>\n<strong>Hemophilia Market, By Type (Revenue, USD Billion, 2021 &#8211; 2029)<\/strong>\n<\/p>\n<ul>\n<li>\nHemophilia A\n<\/li>\n<li>\nHemophilia B\n<\/li>\n<li>\nHemophilia C\n<\/li>\n<li>\nOthers\n<\/li>\n<\/ul>\n<p>\n<strong>Hemophilia Market, By Treatment (Revenue, USD Billion, 2021 &#8211; 2029)<\/strong>\n<\/p>\n<ul>\n<li>\nProphylaxis\n<\/li>\n<li>\nOn-demand\n<\/li>\n<\/ul>\n<p>\n<strong>Hemophilia Market, By Therapy (Revenue, USD Billion, 2021 &#8211; 2029)<\/strong>\n<\/p>\n<ul>\n<li>\nGene therapy\n<\/li>\n<li>\nReplacement therapy\n<\/li>\n<li>\nITI therapy\n<\/li>\n<\/ul>\n<p>\n<strong>Hemophilia Market, By Region (Revenue, USD Billion, 2021 &#8211; 2029)<\/strong>\n<\/p>\n<p>\n<strong>North America<\/strong>\n<\/p>\n<ul>\n<li>\nU.S.\n<\/li>\n<li>\nCanada\n<\/li>\n<\/ul>\n<p>\n<strong>Europe<\/strong>\n<\/p>\n<ul>\n<li>\nGermany\n<\/li>\n<li>\nFrance\n<\/li>\n<li>\nUK\n<\/li>\n<li>\nSpainoItaly\n<\/li>\n<li>\nRussia\n<\/li>\n<li>\nRest of Europe\n<\/li>\n<\/ul>\n<p>\n<strong>Asia Pacific<\/strong>\n<\/p>\n<ul>\n<li>\nChina\n<\/li>\n<li>\nJapan\n<\/li>\n<li>\nIndia\n<\/li>\n<li>\nAustralia\n<\/li>\n<li>\nSouth Korea\n<\/li>\n<li>\nRest of APAC\n<\/li>\n<\/ul>\n<p>\n<strong>Latin America<\/strong>\n<\/p>\n<ul>\n<li>\nBrazil\n<\/li>\n<li>\nMexico\n<\/li>\n<li>\nArgentina\n<\/li>\n<li>\nRest of LATAM\n<\/li>\n<\/ul>\n<p>\n<strong>Middle East &amp; Africa<\/strong>\n<\/p>\n<ul>\n<li>\nSouth Africa\n<\/li>\n<li>\nSaudi Arabia\n<\/li>\n<li>\nRest of MEA\n<\/li>\n<\/ul>\n<p>\n<strong>Key Topics Covered:<\/strong>\n<\/p>\n<p>\n<strong>1. Research Methodology<\/strong>\n<\/p>\n<p>\n<strong>2. Introduction: Hemophilia<\/strong>\n<\/p>\n<p>\n<strong>3. Executive Summary<\/strong>\n<\/p>\n<p>\n<strong>4. Market Dynamics<\/strong>\n<\/p>\n<p>\n<strong>5. Market Environment Analysis<\/strong>\n<\/p>\n<p>\n<strong>6. COVID-19 Impact Analysis: Hemophilia Market<\/strong>\n<\/p>\n<p>\n<strong>7. Market Analysis by Type<\/strong>\n<\/p>\n<p>\n<strong>8. Market Analysis by Treatment<\/strong>\n<\/p>\n<p>\n<strong>9. Market Analysis by Therapy<\/strong>\n<\/p>\n<p>\n<strong>10. Regional Market Analysis<\/strong>\n<\/p>\n<p>\n<strong>11. North America Hemophilia Market<\/strong>\n<\/p>\n<p>\n<strong>12. Europe Hemophilia Market<\/strong>\n<\/p>\n<p>\n<strong>13. Asia Pacific Hemophilia Market<\/strong>\n<\/p>\n<p>\n<strong>14. Latin America Hemophilia Market<\/strong>\n<\/p>\n<p>\n<strong>15. MEA Hemophilia Market<\/strong>\n<\/p>\n<p>\n<strong>16. Competitor Analysis<\/strong>\n<\/p>\n<p>\n<strong>17. Company Profiles<\/strong>\n<\/p>\n<p>\n<strong>18. Conclusion &amp; Recommendations<\/strong>\n<\/p>\n<p>\n<strong>Companies Mentioned<\/strong>\n<\/p>\n<ul>\n<li>\nNovo Nordisk A\/S (Denmark)\n<\/li>\n<li>\nShire plc (U.S.)\n<\/li>\n<li>\nChugai Pharmaceutical Co. Ltd. (Japan)\n<\/li>\n<li>\nBayer AG (Germany)\n<\/li>\n<li>\nPfizer Inc. (U.S.)\n<\/li>\n<li>\nCSL Behring (U.S.)\n<\/li>\n<li>\nBioMarin (U.S.)\n<\/li>\n<li>\nOctopharma AG (Switzerland)\n<\/li>\n<li>\nGenzyme Corporation (U.S.)\n<\/li>\n<li>\nSpark Therapeutics Inc. (U.S.)\n<\/li>\n<\/ul>\n<p>\nFor more information about this report visit <a target=\"_blank\" href=\"https:\/\/www.researchandmarkets.com\/reports\/5607083\/hemophilia-market-analysis-by-type-type-a-b?utm_source=BW&amp;utm_medium=PressRelease&amp;utm_code=sx9jt6&amp;utm_campaign=1749424+-+Global+Hemophilia+Market+Report+2022%3A+Rising+Adoption+of+Prophylaxis+Treatment+to+Drive+Sector+Growth&amp;utm_exec=como322prd\" rel=\"nofollow noopener\" shape=\"rect\">https:\/\/www.researchandmarkets.com\/r\/epche1<\/a>\n<\/p>\n<p> <b>Contacts<\/b> <\/p>\n<p>\nResearchAndMarkets.com<br \/>\n<br \/>Laura Wood, Senior Press Manager<br \/>\n<br \/><a target=\"_blank\" href=\"&#109;&#x61;&#105;&#x6c;&#116;&#x6f;&#58;&#x70;r&#x65;s&#x73;&#64;&#x72;e&#115;&#x65;&#97;&#x72;&#99;&#x68;&#97;&#x6e;&#100;&#x6d;a&#x72;k&#x65;t&#x73;&#46;&#99;&#x6f;&#109;\" rel=\"nofollow noopener\" shape=\"rect\">&#x70;&#x72;&#101;&#115;&#115;&#64;&#x72;&#x65;&#x73;&#101;&#97;rc&#x68;&#x61;&#x6e;&#100;&#109;a&#x72;&#x6b;&#x65;&#116;&#115;&#46;c&#x6f;&#x6d;<\/a><br \/>For E.S.T Office Hours Call 1-917-300-0470<br \/>\n<br \/>For U.S.\/ CAN Toll Free Call 1-800-526-8630<br \/>\n<br \/>For GMT Office Hours Call +353-1-416-8900\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>DUBLIN&#8211;(BUSINESS WIRE)&#8211;The &#8220;Hemophilia Market Analysis by Type (Type A, B, C,), by Treatment (Prophylaxis, On-Demand), by Therapy (Gene, Replacement, Immune Tolerance Induction (ITI) Therapy), and by Region &#8211; Forecast to 2029&#8221; report has been added to ResearchAndMarkets.com&#8217;s offering. The global hemophilia market size is estimated to be USD 12.6 billion in 2021 and is expected &#8230; <span class=\"more\"><a class=\"more-link\" href=\"https:\/\/pharma-trend.com\/en\/global-hemophilia-market-report-2022-rising-adoption-of-prophylaxis-treatment-to-drive-sector-growth-researchandmarkets-com\/\">[Read more&#8230;]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-48353","6":"format-standard","7":"category-industry"},"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Global Hemophilia Market Report 2022: Rising Adoption of Prophylaxis Treatment to Drive Sector Growth - ResearchAndMarkets.com - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/global-hemophilia-market-report-2022-rising-adoption-of-prophylaxis-treatment-to-drive-sector-growth-researchandmarkets-com\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Global Hemophilia Market Report 2022: Rising Adoption of Prophylaxis Treatment to Drive Sector Growth - ResearchAndMarkets.com - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"DUBLIN&#8211;(BUSINESS WIRE)&#8211;The &#8220;Hemophilia Market Analysis by Type (Type A, B, C,), by Treatment (Prophylaxis, On-Demand), by Therapy (Gene, Replacement, Immune Tolerance Induction (ITI) Therapy), and by Region &#8211; Forecast to 2029&#8221; report has been added to ResearchAndMarkets.com&#8217;s offering. The global hemophilia market size is estimated to be USD 12.6 billion in 2021 and is expected ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/global-hemophilia-market-report-2022-rising-adoption-of-prophylaxis-treatment-to-drive-sector-growth-researchandmarkets-com\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2022-09-14T10:01:56+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20220914005481\/en\/1571401\/21\/logo.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-hemophilia-market-report-2022-rising-adoption-of-prophylaxis-treatment-to-drive-sector-growth-researchandmarkets-com\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-hemophilia-market-report-2022-rising-adoption-of-prophylaxis-treatment-to-drive-sector-growth-researchandmarkets-com\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Global Hemophilia Market Report 2022: Rising Adoption of Prophylaxis Treatment to Drive Sector Growth &#8211; ResearchAndMarkets.com\",\"datePublished\":\"2022-09-14T10:01:56+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-hemophilia-market-report-2022-rising-adoption-of-prophylaxis-treatment-to-drive-sector-growth-researchandmarkets-com\\\/\"},\"wordCount\":500,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-hemophilia-market-report-2022-rising-adoption-of-prophylaxis-treatment-to-drive-sector-growth-researchandmarkets-com\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220914005481\\\/en\\\/1571401\\\/21\\\/logo.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-hemophilia-market-report-2022-rising-adoption-of-prophylaxis-treatment-to-drive-sector-growth-researchandmarkets-com\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-hemophilia-market-report-2022-rising-adoption-of-prophylaxis-treatment-to-drive-sector-growth-researchandmarkets-com\\\/\",\"name\":\"Global Hemophilia Market Report 2022: Rising Adoption of Prophylaxis Treatment to Drive Sector Growth - ResearchAndMarkets.com - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-hemophilia-market-report-2022-rising-adoption-of-prophylaxis-treatment-to-drive-sector-growth-researchandmarkets-com\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-hemophilia-market-report-2022-rising-adoption-of-prophylaxis-treatment-to-drive-sector-growth-researchandmarkets-com\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220914005481\\\/en\\\/1571401\\\/21\\\/logo.jpg\",\"datePublished\":\"2022-09-14T10:01:56+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-hemophilia-market-report-2022-rising-adoption-of-prophylaxis-treatment-to-drive-sector-growth-researchandmarkets-com\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-hemophilia-market-report-2022-rising-adoption-of-prophylaxis-treatment-to-drive-sector-growth-researchandmarkets-com\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-hemophilia-market-report-2022-rising-adoption-of-prophylaxis-treatment-to-drive-sector-growth-researchandmarkets-com\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220914005481\\\/en\\\/1571401\\\/21\\\/logo.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220914005481\\\/en\\\/1571401\\\/21\\\/logo.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-hemophilia-market-report-2022-rising-adoption-of-prophylaxis-treatment-to-drive-sector-growth-researchandmarkets-com\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Global Hemophilia Market Report 2022: Rising Adoption of Prophylaxis Treatment to Drive Sector Growth &#8211; ResearchAndMarkets.com\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Global Hemophilia Market Report 2022: Rising Adoption of Prophylaxis Treatment to Drive Sector Growth - ResearchAndMarkets.com - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/global-hemophilia-market-report-2022-rising-adoption-of-prophylaxis-treatment-to-drive-sector-growth-researchandmarkets-com\/","og_locale":"en_US","og_type":"article","og_title":"Global Hemophilia Market Report 2022: Rising Adoption of Prophylaxis Treatment to Drive Sector Growth - ResearchAndMarkets.com - Pharma Trend","og_description":"DUBLIN&#8211;(BUSINESS WIRE)&#8211;The &#8220;Hemophilia Market Analysis by Type (Type A, B, C,), by Treatment (Prophylaxis, On-Demand), by Therapy (Gene, Replacement, Immune Tolerance Induction (ITI) Therapy), and by Region &#8211; Forecast to 2029&#8221; report has been added to ResearchAndMarkets.com&#8217;s offering. The global hemophilia market size is estimated to be USD 12.6 billion in 2021 and is expected ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/global-hemophilia-market-report-2022-rising-adoption-of-prophylaxis-treatment-to-drive-sector-growth-researchandmarkets-com\/","og_site_name":"Pharma Trend","article_published_time":"2022-09-14T10:01:56+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20220914005481\/en\/1571401\/21\/logo.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/global-hemophilia-market-report-2022-rising-adoption-of-prophylaxis-treatment-to-drive-sector-growth-researchandmarkets-com\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/global-hemophilia-market-report-2022-rising-adoption-of-prophylaxis-treatment-to-drive-sector-growth-researchandmarkets-com\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Global Hemophilia Market Report 2022: Rising Adoption of Prophylaxis Treatment to Drive Sector Growth &#8211; ResearchAndMarkets.com","datePublished":"2022-09-14T10:01:56+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/global-hemophilia-market-report-2022-rising-adoption-of-prophylaxis-treatment-to-drive-sector-growth-researchandmarkets-com\/"},"wordCount":500,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/global-hemophilia-market-report-2022-rising-adoption-of-prophylaxis-treatment-to-drive-sector-growth-researchandmarkets-com\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20220914005481\/en\/1571401\/21\/logo.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/global-hemophilia-market-report-2022-rising-adoption-of-prophylaxis-treatment-to-drive-sector-growth-researchandmarkets-com\/","url":"https:\/\/pharma-trend.com\/en\/global-hemophilia-market-report-2022-rising-adoption-of-prophylaxis-treatment-to-drive-sector-growth-researchandmarkets-com\/","name":"Global Hemophilia Market Report 2022: Rising Adoption of Prophylaxis Treatment to Drive Sector Growth - ResearchAndMarkets.com - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/global-hemophilia-market-report-2022-rising-adoption-of-prophylaxis-treatment-to-drive-sector-growth-researchandmarkets-com\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/global-hemophilia-market-report-2022-rising-adoption-of-prophylaxis-treatment-to-drive-sector-growth-researchandmarkets-com\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20220914005481\/en\/1571401\/21\/logo.jpg","datePublished":"2022-09-14T10:01:56+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/global-hemophilia-market-report-2022-rising-adoption-of-prophylaxis-treatment-to-drive-sector-growth-researchandmarkets-com\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/global-hemophilia-market-report-2022-rising-adoption-of-prophylaxis-treatment-to-drive-sector-growth-researchandmarkets-com\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/global-hemophilia-market-report-2022-rising-adoption-of-prophylaxis-treatment-to-drive-sector-growth-researchandmarkets-com\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20220914005481\/en\/1571401\/21\/logo.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20220914005481\/en\/1571401\/21\/logo.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/global-hemophilia-market-report-2022-rising-adoption-of-prophylaxis-treatment-to-drive-sector-growth-researchandmarkets-com\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Global Hemophilia Market Report 2022: Rising Adoption of Prophylaxis Treatment to Drive Sector Growth &#8211; ResearchAndMarkets.com"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/48353","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=48353"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/48353\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=48353"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=48353"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=48353"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}